Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 12 of 12 for “"Neuroprotective therapy"”.

  1. Translating torpor into a neuroprotective therapy for acute stroke: an investigation of its electrophysiological and neuroprotective properties

    … indicate that hypothermia is the most potent neuroprotective strategy for stroke. However, existing hypothermic therapies have so far been largely unsuccessful in clinical trials, with compensatory thermogenesis being a contributing factor. However, thermogenesis is suppressed in torpor, which …

    oxford Repository record for Translating torpor into a neuroprotective therapy for acute stroke: an investigation of its electrophysiological and neuroprotective properties (opens in a new tab)

  2. Discovery of a selective GluN2A-containing N-methyl-d-aspartate glutamate receptor positive modulator as a novel post-stroke neuroprotective therapy

    N-methyl-d-aspartate glutamate receptors (NMDARs) are fundamental to many normal brain functions such as cognition and memory; however, NMDAR over-activation can cause neuronal death as a result of excitotoxicity. Although the mechanisms underlying these paradoxical roles of NMDARs remain unclear, …

    ubc Repository record for Discovery of a selective GluN2A-containing N-methyl-d-aspartate glutamate receptor positive modulator as a novel post-stroke neuroprotective therapy (opens in a new tab) Download PDF for Discovery of a selective GluN2A-containing N-methyl-d-aspartate glutamate receptor positive modulator as a novel post-stroke neuroprotective therapy (opens in a new tab)

  3. BNIP3: A POTENTIAL TARGET FOR THE TREATMENT OF MITOCHONDRIAL DYSFUNCTION IN HUNTINGTON'S DISEASE.

    … since the discovery of the HD mutation, no therapy has shown a neuroprotective effect or has been shown to slow down the disease progression to date. Growing evidence supports a pivotal role for mitochondrial dysfunction in the death of patients’ neurons but the molecular bases for …

    milano Repository record for BNIP3: A POTENTIAL TARGET FOR THE TREATMENT OF MITOCHONDRIAL DYSFUNCTION IN HUNTINGTON'S DISEASE. (opens in a new tab)

  4. Tailoring allosteric modulators of NMDA receptors and GABA-A receptors for neurological disorders

    … potentials as a new and more effective class of neuroprotective therapy for stroke, we performed computer-aided virtual screening and in-silico drug design to discover a lead compound 813 that functions as an NMDAR dual allosteric modulator (Ndam) that potentiates GluN1/GluN2A and at the same …

    ubc Repository record for Tailoring allosteric modulators of NMDA receptors and GABA-A receptors for neurological disorders (opens in a new tab) Download PDF for Tailoring allosteric modulators of NMDA receptors and GABA-A receptors for neurological disorders (opens in a new tab)

  5. Photobiomodulation Laser in Retinal Degeneration

    … Hence, PBM would be a novel bioenergetics neuroprotective therapy for retinal degenerative disease including RP. Past studies have examined light-emitting diode (LED) based PBM on retina however there is concern of scattering and filtering of incoherent light. Moreover, there is no …

    adelaide Repository record for Photobiomodulation Laser in Retinal Degeneration (opens in a new tab)

  6. Pharmacokinetics and Pharmacodynamics of Riluzole in Acute Spinal Cord Injury Patients

    … the time-variant pharmacokinetics of a potential neuroprotective therapy, riluzole, and its pharmacodynamic effects on an axonal injury biomarker, pNF-H and motor functions. We aimed to: (1) Characterize the longitudinal impacts of SCI on the pharmacokinetics (PK) of riluzole. A one-compartment …

    houston Repository record for Pharmacokinetics and Pharmacodynamics of Riluzole in Acute Spinal Cord Injury Patients (opens in a new tab)

  7. Desenvolvimento e avaliação da atividade neuroprotetora de nanoemulsões revestidas por quitosana contendo ácido rosmarínico administradas pela via nasal

    As doenças neurodegenerativas (DN) são caracterizadas pela perda lenta e progressiva neuronal, com limitadas estratégias terapêuticas capazes de evitar sua progressão. O ácido rosmarínico (AR) é um composto encontrado em várias espécies vegetais com potencial neuroprotetor bem descrito na …

    brazil-ufrgs Repository record for Desenvolvimento e avaliação da atividade neuroprotetora de nanoemulsões revestidas por quitosana contendo ácido rosmarínico administradas pela via nasal (opens in a new tab)

  8. Differential Diagnosis of Parkinsonism and Tremor Disorders: Basal Ganglia Imaging With a Novel Isotope

    … disease progression and the effects of putative neuroprotective therapy. In conclusion, this new technique represents a significant advance in medical diagnosis of movement disorders..

    glasgow Download PDF for Differential Diagnosis of Parkinsonism and Tremor Disorders: Basal Ganglia Imaging With a Novel Isotope (opens in a new tab)

  9. Machine learning techniques for identifying early-life biomarkers in perinatal & child health

    … early life marker for those with HIE in need of neuroprotective therapy. The second validation study successfully validated our algorithm for the prediction of HIE in a large diverse cohort comprised of infants with a range of differing conditions, compared to a set of HIE cases and controls …

    cork Repository record for Machine learning techniques for identifying early-life biomarkers in perinatal & child health (opens in a new tab) Embargoed until 2028-12-31

  10. Syntheses of chalcones and 2–aminopyrimidines and their evaluation as monoamine oxidase inhibitors and as adenosine receptor antagonists

    … as symptomatic treatment, but also as potential neuroprotective therapy. Adenosine A2A receptors are co-localised with dopamine D2 receptors in the striatum and other nuclei of the basal ganglia. Adenosine A2A stimulation decreases the affinity of dopamine for the D2 receptor, and increase cyclic …

    nwu-za Repository record for Syntheses of chalcones and 2–aminopyrimidines and their evaluation as monoamine oxidase inhibitors and as adenosine receptor antagonists (opens in a new tab)

  11. EXPRESSION OF FOS AND MICROGLIAL REACTION FOLLOWING OCCLUSION OF THE MIDDLE CEREBRAL ARTERY IN RATS

    … suggesting that their activation may be neuroprotective in function. How this may be effected would be scope for future study, although from a speculative point of view, this may be mediated through secretion of nerve growth factors beneficial for the ventral horn neurons. A better …

    nus Repository record for EXPRESSION OF FOS AND MICROGLIAL REACTION FOLLOWING OCCLUSION OF THE MIDDLE CEREBRAL ARTERY IN RATS (opens in a new tab) Download file for EXPRESSION OF FOS AND MICROGLIAL REACTION FOLLOWING OCCLUSION OF THE MIDDLE CEREBRAL ARTERY IN RATS (opens in a new tab)

  12. O ρόλος των κλινικών επιδράσεων του IRL-1620 σε πειραματικό μοντέλο τραυματισμού του νωτιαίου μυελού

    … This study suggests that sovateltide may offer neuroprotective effects, enhancing neurogenesis and angiogenesis. Furthermore, it may possess anti-inflammatory and anti-nociceptive properties. Future clinical trials are needed to validate these findings, but sovateltide shows promise as a …

    greece Repository record for O ρόλος των κλινικών επιδράσεων του IRL-1620 σε πειραματικό μοντέλο τραυματισμού του νωτιαίου μυελού (opens in a new tab)